99 CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS)-DEFINED HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS)
Garcia-Manero, G., Savona, M.R., Gore, S.D., Cogle, C.R., Conkling, P., Hetzer, J., Dong, Q., Ukrainskyj, S.M., Skikne, B.S.Volume:
39
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/S0145-2126(15)30100-4
Date:
April, 2015
File:
PDF, 155 KB
english, 2015